Why does the unit conversion vary for tirzepatide?
Compounded tirzepatide, unlike Zepbound auto-injector pens, is supplied as a vial with a specific concentration expressed as milligrams per milliliter (mg/mL). The same 5mg dose drawn from two different vials with different concentrations will require completely different volumes — and therefore different unit measurements on an insulin syringe.
Insulin syringes are calibrated in units, where 100 units = 1mL for U-100 syringes (the standard). So the conversion chain is:
Formula:
Volume (mL) = Dose (mg) ÷ Concentration (mg/mL)
Units = Volume (mL) × 100
Combined:
Units = (Dose in mg ÷ Concentration in mg/mL) × 100
Unit conversion table for 5mg of tirzepatide
Applying that formula to common compounded tirzepatide concentrations for a 5mg dose:
| Concentration | Volume for 5mg | Units (U-100 syringe) |
|---|---|---|
| 2.5 mg/mL | 2.0 mL | 200 units |
| 5 mg/mL | 1.0 mL | 100 units |
| 10 mg/mL | 0.5 mL | 50 units |
| 12.5 mg/mL | 0.4 mL | 40 units |
Important: Always verify the concentration on your specific pharmacy label before using this table. Concentrations vary by pharmacy and may change between refills.
Quick reference: other common tirzepatide doses
For a 5mg/mL vial (a commonly used concentration), here are the unit equivalents for doses in the standard titration range:
| Dose | Volume at 5mg/mL | Units (U-100) |
|---|---|---|
| 2.5 mg | 0.5 mL | 50 units |
| 5 mg | 1.0 mL | 100 units |
| 7.5 mg | 1.5 mL | 150 units |
| 10 mg | 2.0 mL | 200 units |
| 12.5 mg | 2.5 mL | 250 units |
Note: Recalculate completely if your vial concentration differs from 5mg/mL.
“Units” on a syringe measure volume, not drug — 5 mg is never 5 units, and the conversion always starts from your vial’s concentration.
Common mistakes in tirzepatide unit calculation
Dosing errors with compounded injectables are a real safety concern. The most common mistakes:
- Assuming the same units across refills: Concentrations can change when a pharmacy reformulates or when a different vial size is dispensed. Always re-read the label on every new vial.
- Confusing mg with units:5mg is not the same as 5 units. “Units” on a syringe are volume units (1/100th of a mL on a U-100 syringe), not milligrams of drug.
- Using a non-U-100 syringe: Some syringes are U-50 or volume-graduated in mL only. The unit markings will not match U-100 conversion math. Use the syringe type specified in your prescription instructions.
- Guessing when unsure: There is no safe rationale for guessing. Contact your prescribing clinician or pharmacy before administering any dose you are uncertain about.
Why does compounded tirzepatide require an active clinical relationship?
Zepbound auto-injector pens eliminate the dose calculation step — the pen delivers a fixed dose with a single click. Compounded tirzepatide in vials requires the patient to calculate and draw their own dose correctly. This is not inherently dangerous, but it does mean the clinical relationship is an active safety component, not a formality.
A responsible tirzepatide program from a licensed telehealth provider includes:
- Written instructions specifying concentration, dose in mg, volume in mL, and units
- A clinician or pharmacist available to answer dosing questions
- Medication dispensed from a licensed 503A compounding pharmacy in the USA with a labeled concentration
- A titration schedule managed by the clinician, not self-directed
Compounded tirzepatide is not an FDA-approved drug — it is a compounded preparation prepared by a licensed pharmacy. It delivers the same active molecule at the prescribed dose when prepared and administered correctly. “Correctly” depends on the concentration on the label, which is why that label is the starting point for every dose calculation.
Frequently asked questions
How many units is 5mg of tirzepatide?
The number of units for 5mg of tirzepatide depends entirely on the concentration of your specific vial. At a common compounded concentration of 5mg/mL, 5mg = 1mL = 100 units on an insulin syringe. At 10mg/mL, 5mg = 0.5mL = 50 units. At 2.5mg/mL, 5mg = 2mL = 200 units. Always confirm the concentration printed on your pharmacy label before drawing any dose. Never assume concentration across refills — it can change.
How do I calculate tirzepatide units from mg?
Formula: Units = (Dose in mg ÷ Concentration in mg/mL) × 100. Example: 5mg dose, 5mg/mL vial → (5 ÷ 5) × 100 = 100 units. Example: 2.5mg dose, 10mg/mL vial → (2.5 ÷ 10) × 100 = 25 units. The "×100" converts mL to units as read on an insulin syringe (1mL = 100 units on a U-100 syringe). Confirm your syringe is U-100 marked.
What are common tirzepatide concentrations from compounding pharmacies?
Compounded tirzepatide concentrations vary by pharmacy and by the patient's prescribed dose regimen. Common concentrations include 2.5mg/mL, 5mg/mL, and 10mg/mL, though pharmacies may formulate at other concentrations. The concentration should always be clearly labeled on your vial. If the label does not specify concentration, contact the pharmacy before drawing any dose.
What syringe should I use for tirzepatide injections?
Compounded tirzepatide is typically administered with insulin syringes (U-100, 1mL). The unit markings on a U-100 syringe measure in units where 100 units = 1mL. This makes unit-to-volume conversion consistent across U-100 syringes. Some pharmacies use volume-marked (mL) syringes instead — in that case, calculate the volume in mL directly and draw to that marking. Follow the instructions provided with your prescription.
Is 5mg of tirzepatide the standard starting dose?
The FDA-approved Zepbound starting dose is 2.5mg weekly, titrated to 5mg at week 5, then potentially to higher doses (7.5mg, 10mg, 12.5mg, 15mg). Clinician-supervised compounded tirzepatide protocols often follow similar titration schedules, but the specific starting dose and titration pace are individualized by the prescribing clinician based on the patient's history, weight, and tolerance. Never self-adjust your dose without clinician guidance.
What should I do if I'm unsure about my tirzepatide dose?
Contact your prescribing clinician or the dispensing pharmacy before administering any dose you are uncertain about. Dosing errors in either direction — underdosing or overdosing — have real consequences. A responsible telehealth provider will have a clear process for answering dosing questions. If your provider is not accessible for this type of question, that is a quality-of-care concern worth raising.